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Abstract
Background: Induced abortion is one of the safest procedures for unwanted pregnancies in medical practice. Vacuum
aspiration is the preferred method for uterine evacuation before 12 weeks of pregnancy.
Objectives: To study the efﬁcacy of manual vacuum aspiration (MVA) in o8 wk versus 8–12 wk of pregnancy.
Materials and Methods: A randomized comparative prospective study was performed at the Department of Obstetrics and
Gynaecology, P D U Medical College, Rajkot, over a period of January 2012 to June 2013. Totally, 100 subjects were
enrolled in the study, which were further divided into two groups (o8 wk and 8–12 wk of pregnancy, 50 in each). MVA was
performed in both the groups, and comparison was done in view to evaluate completeness of procedure, requirement of
add-on procedure, and complications.
Results: Of 50 subjects in each group, perforation was found in two cases in group A and one case in group B.
Requirement of oxytocics noted in only one case in group B, whereas incomplete abortion noted in two cases in group A
and three in group B. All complications were found statistically insigniﬁcant (P = 1) between both the groups.
Conclusion: This study focused on the efﬁcacy of MVA in higher weeks of gestations, which was equal in both the groups.
Thus, MVA is a safe and an acceptable procedure up to 12 wk of pregnancy.
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Introduction
Early pregnancy loss, also known as miscarriage or
abortion, is a common experience for women and responsible
for the maximum number of pregnancy losses.[1] Miscarriage
of an early pregnancy is the commonest medical complication,
affecting 10–20% of clinically recognized pregnancies.[2]
Of the estimated 211 million pregnancies worldwide that occur
each year, about 46 million are terminated by induced
abortion.[3] According to WHO, each day, 192 women die
because of complications arising from unsafe abortions.[4]
Despite advancement in the medical technology, unsafe
abortion-related complications contribute to 10–13% of maternal
deaths in the developing countries.[5]
Induced abortion is one of the safest procedures in medical
practice. Hence, India legalized this induced abortions through
Medical Termination of Pregnancy (MTP) act. National
population policy 2000 of India has made goal to decentralize
abortion services and adoption of new technology for MTP.[6]
Vacuum aspiration involves the evacuation of the contents
of the uterus through a plastic or metal cannula, attached to a
vacuum source. Electric vacuum aspiration (EVA) employs an
electric vacuum pump. In manual vacuum aspiration (MVA),
the vacuum is created using a handheld, hand-activated,
plastic syringe. MVA has been in use for more than 30 years
with varying opinions on its safety from different experts.[7]
Vacuum aspiration is safer than sharp curettage, and the
WHO recommends vacuum aspiration as the preferred method
for uterine evacuation before 12 weeks of pregnancy.[8] This
method is faster, safer, more comfortable, and associated
with shorter hospital stay for induced abortion than sharp
curettage.[9,10] Additional advantages compared with sharp
curettage are its ease of use as an outpatient procedure, the
need for less analgesia and anesthesia,[10] and its lower cost
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per procedure especially if performed on an outpatient
basis.[12] It is also included under National Rural Health
Mission and safe abortion services.[6] MVA, with its advan-
tages of simplicity, nondependence on power supply, and
comparable or even low complication rates, is emerging as the
preferred method for ﬁrst trimester pregnancy termination.[13]
MVA can be done up to 12 wk of pregnancy, but certain
studies recommend up to only 10 wk and more incomplete-
ness in higher weeks of pregnancy. Hence, we carried out this
study to evaluate its efﬁcacy up to 12 wk.
Materials and Methods
We conducted a randomized comparative prospective study
at the Department of Obstetrics and Gynaecology, P. D. U.
Medical College, Rajkot, over a period of January 2012 to June
2013. Totally, 100 subjects were enrolled in our study, which
were divided into two groups (group A, o8 wk of pregnancy
and group B, 8–12 wk of pregnancy; 50 in each).
Patients who visited OPD for induced abortion were
selected according to the weeks of gestation after detailed
history and examination. Written and informed consent was
taken. Routine investigations were performed in all subjects.
Cervical ripening was achieved with 400 mg misoprostol
tablet before 2 hours. In both the groups, Ipas MVA syringe
was used for the MTP. Completeness of procedure, requirement
of add-on procedure (EVA or curettage), and complications
were noted. Patients were discharged on the same day after
4–6 hours of procedure if no complication occurred. Patients
were called for follow up in OPD on 7th and 15th day. The
follow up was compiled and documented.
Results
Totally, 100 subjects were included in the study. In both the
groups, patients of different age, parity, and area of residence
were included (Table 1). Perforation of uterus was noted in
two cases in group A, whereas in one case in group B (P = 1,
insigniﬁcant). All patients with perforation were treated
conservatively. Only one case in group B required oxytocics
drug during the procedure, whereas no such case noted
in group A (P = 1, insigniﬁcant). Incomplete abortion was found
in two cases in group A, whereas in three cases in group B
(P = 1, insigniﬁcant). All cases of incomplete abortion were
treated by simple curettage.
Discussion
In our study, the mean age was 26.3 yr in group A and
25.8 yr in group B. The efﬁcacy of the procedure was 96% in
group A (o8 wk) and 94% in group B (8–12 wk) in our study.
The complication rates were 8% in group A and 10% in
group B; add-on procedure (check curettage) was required
in 4% in group A and 6% in group B.
Many studies have been published about the efﬁcacy
and complications of MVA. Samal et al.[14] evaluated MVA and
EVA in ﬁrst trimester and found 97% effectiveness of MVA,
similar to our study. Paul et al.[15] showed 98% efﬁcacy for
MVA, also almost similar to our study. Begum et al.[16] studied
the management of incomplete abortion by MVA and found
effectiveness of the procedure to be about 98% with very low
postprocedure complication rate (2%).
MVA requires marginally more time compared to EVA,
especially at higher weeks of gestation. In this study, we tried
to ﬁnd out the effectiveness of MVA in higher gestations and
evidences of retained products. Yet, this is a smaller study;
more studies should be performed on larger grounds.
Nine of 100 maternal deaths are because of unsafe
abortions. Hence, comprehensive abortion care has been
started under National Rural Health Mission. Introduction of
the MVA technique is useful to expand safe abortion services
in remote areas. The MVA technique is a safe and simple for
MTP, which makes it feasible even at Primary Health Centre or
Community Health Center levels.[6] Thus, we concluded that
procedure is equally efﬁcacious in o8 wk and 8–12 wk of
pregnancy. So, MVA is a safe and an acceptable procedure up
to 12 wk of pregnancy.
Conclusion
This study focused on efﬁcacy of MVA in higher weeks of
gestations. All noted complications were found statistically
insigniﬁcant between both the groups. The efﬁcacy of the
Table 1: General observations
Group A Group B
Age (yr)
o20 1 2
20–30 40 35
430 9 13
Parity
1 8 10
2 22 23
3 18 10
X4 2 7
Area
Urban 38 39
Rural 12 11
Table 2: Complications
Complications Group A Group B
Perforation 2 1
Required oxytocics 0 1
Incomplete abortion
(add-on procedure required)
2 3
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procedure was 96% in group A and 94% in group B. Thus, we
conclude that procedure is equally efﬁcacious in o8 wk and
8–12 wk of pregnancy. Hence, MVA is a safe and an
acceptable procedure up to 12 wk of pregnancy.
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